Quantcast
Last updated on April 16, 2014 at 6:45 EDT

Latest Warner Chilcott Plc Stories

2014-01-14 08:29:22

DUBLIN, Jan. 14, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that, based on a preliminary review of 2013 results for the fourth quarter ended December 31, 2013, the Company expects non-GAAP earnings per diluted share for the fourth quarter 2013 to be modestly above the high end of its previous forecast. "2013 was a transformational year for Actavis, highlighted by the acquisition of Warner Chilcott plc and continued exceptional performance across our global...

2013-10-02 08:30:32

DUBLIN, Oct. 2, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the appointment of its Board of Directors, effective until the next annual meeting of shareholders in May 2014. The appointment of the Actavis plc Board follows the completion of Actavis, Inc.'s acquisition of Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. The combination creates Actavis plc, a leading global specialty pharmaceutical company with...

2013-09-30 12:27:01

PARSIPPANY, N.J. and DUBLIN, Sept. 30, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that the Irish High Court has approved Actavis' pending acquisition of Warner Chilcott. The parties have now obtained all regulatory approvals required to complete the transaction. The closing remains subject to satisfaction of other customary closing conditions and is expected to occur as soon as practicable after satisfaction of those...

2013-09-27 16:23:37

PARSIPPANY, N.J. and DUBLIN, Sept. 27, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Actavis' proposed acquisition of Warner Chilcott. The vote in support of the transaction follows Actavis' agreement to a proposed consent order, pursuant to which Actavis has agreed to divest certain products as a condition to obtaining FTC approval. The closing of the transaction...

2013-09-10 08:32:15

PARSIPPANY, N.J. and DUBLIN, Sept. 10, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that, at shareholder meetings held today, proposals related to Actavis' proposed acquisition of Warner Chilcott were approved by both Actavis' and Warner Chilcott's shareholders.Actavis' and Warner Chilcott's shareholder approvals satisfy certain conditions to the closing of the transaction. The closing of the transaction remains subject to...

2013-08-29 08:25:16

PARSIPPANY, N.J., Aug. 29, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that all three leading independent proxy advisory firms -- Institutional Shareholder Services (ISS), Glass Lewis and Egan-Jones -- have recommended that Actavis shareholders vote in favor of adopting the transaction agreement in which Actavis will acquire Warner Chilcott plc (NASDAQ: WCRX) through the formation of a new holding company incorporated in Ireland, expected to be named Actavis plc....

2013-08-09 08:25:04

PARSIPPANY, N.J. and DUBLIN, Aug. 9, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that they have received approval from the French Competition Authority for Actavis' pending acquisition of Warner Chilcott. The companies previously received approval from the German Federal Cartel Office and have now received all ex-U.S. antitrust clearances required to complete the transaction. About ActavisActavis, Inc. (NYSE: ACT) is a...

2013-08-02 16:23:30

PARSIPPANY, N.J., Aug. 2, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), today announced that Actavis Limited, Bank of America, N.A., as Administrative Agent and a syndicate of banks participating as lenders have entered into a new senior unsecured term loan credit and guaranty agreement, pursuant to which the lenders party to the agreement will provide loans, on the closing date of Actavis' proposed acquisition of Warner Chilcott plc (the "Closing Date"), to certain entities of...

2013-07-31 16:28:38

-- Companies Schedule Shareholder Meetings for September 10, 2013 -- PARSIPPANY, N.J. and DUBLIN, July 31, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that the registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission ("SEC") by Actavis Limited ("New Actavis") on June 18, 2013 and amended on July 31, 2013 (the "Form S-4"), which includes a joint proxy statement of Actavis and Warner Chilcott,...

2013-07-23 08:31:19

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 23, 2013 /PRNewswire/ -- On Monday, July 22, 2013, shares in drug companies ended mostly higher, tracking gains in the broader market which posted small gains. The major movers in the industry included Dynavax Technologies Corporation (NASDAQ: DVAX), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), Warner Chilcott Plc (NASDAQ: WCRX), and Actavis Inc. (NYSE: ACT). All these companies are...